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Abstract
Characterizing infectivity as a function of pathogen dose is integral to microbial risk assessment. Dose-response
experiments usually administer doses to subjects at one time. Phenomenological models of the resulting data, such as the
exponential and the Beta-Poisson models, ignore dose timing and assume independent risks from each pathogen. Real
world exposure to pathogens, however, is a sequence of discrete events where concurrent or prior pathogen arrival affects
the capacity of immune effectors to engage and kill newly arriving pathogens. We model immune effector and pathogen
interactions during the period before infection becomes established in order to capture the dynamics generating dose
timing effects. Model analysis reveals an inverse relationship between the time over which exposures accumulate and the
risk of infection. Data from one time dose experiments will thus overestimate per pathogen infection risks of real world
exposures. For instance, fitting our model to one time dosing data reveals a risk of 0.66 from 313 Cryptosporidium parvum
pathogens. When the temporal exposure window is increased 100-fold using the same parameters fitted by our model to
the one time dose data, the risk of infection is reduced to 0.09. Confirmation of this risk prediction requires data from
experiments administering doses with different timings. Our model demonstrates that dose timing could markedly alter the
risks generated by airborne versus fomite transmitted pathogens.
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Introduction
Microbial risk assessment models are valuable tools for
estimating the risks associated with exposures to pathogens in
the environment pathogens [1]. Central to this estimate is a dose-
response model that predicts the probability of infection given a
dose exposure magnitude. In current microbial risk assessment
models dose accumulates over time and the probability of infection
is based on the total accumulated dose over that period of time [2–
4]. This assumes that each pathogen particle carries a risk of
infection that is independent of when other pathogens have
arrived to a host; i.e., three exposures to dose X generate the same
total risk as one exposure to a 36dose. We put forth an alternative
dose response model that assumes the current capacity of immune
effectors to control an arriving pathogen should be affected by 1)
how many effectors are occupied fighting previously or simulta-
neously arriving pathogens, 2) how many effectors have been
depleted in fighting previously arriving pathogens, and 3) how
many effector reinforcements have arrived due to usual effector
turnover rates or due to a stimulus from prior pathogen exposure.
If dose-timing effects arise from such immune effector dynamics,
then infection-risk calculations that do not take these dose-timing
effects into account could lead to errors. For example, errors could
arise in models of influenza transmission as follows. Pathogens
arriving to a host via aerosols do so more frequently but at lower
doses than pathogens arriving via hand or fomite mediated
inoculations. Models of influenza transmission that do not account
for dose-timing effects, such as the model by Atkinson and Wien
[4], might misdirect influenza control resources to masks from
hand hygiene. Models that assume independent single dose effects
will require more extreme cleaning to reduce risks to acceptable
levels than models capturing immune effects on dose timing.
Evaluating the potential importance of such dose-timing effects
is difficult for two reasons. First, immune control of pathogens is
complex; not enough detailed knowledge regarding that complex-
ity is available to provide a high degree of confidence in a-priori
causal model predictions. Second, there is almost no direct
observational data documenting the presence or absence of dose-
timing effects. Although various studies have given pathogen
exposure doses over time [5–10], only Brachman et al. [11], has
been conducted in a manner that allows one to calculate risks for
comparable doses administered over different temporal windows.
In this paper we have taken an approach intended to stimulate
science that will address both of these issues. We develop a simple
model that illustrates the need to generate new data that can
describe dose-timing effects while at the same time providing a
base upon which to build more realistic models that incorporate
more data and theory on immunity. Our model addresses
immune control of pathogens between the time pathogens arrive
at a host and the time they are either eliminated or have
multiplied enough so that an acquired immune response will be
needed for control.
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pathogen control that might arise from established antibodies and
T-cells, macrophages, polymorphonuclear leukocytes, plasma
cells, dendritic cells, complement cascades, chemokines, interleu-
kins, interferons, toll like receptors, and other diverse elements
affecting immunity. But we lump all these mediators of pathogen
control into a highly abstract entity we label as immune effectors.
We assume that the dynamic effects of limited immune effector
numbers are similar whether the limitation arises from immune
effectors being occupied with previously arrived pathogens or from
prior consumption of immune effectors in their process of killing
pathogens. Therefore we only model the latter source of immune
effector limitations. The resulting model is one where any single
pathogen always has some chance of initiating an infection but the
risk of infection associated with each additional pathogen exposure
can markedly increase at higher pathogen doses given over short
temporal windows. The exact dynamics of our model will vary as
realistic details are added to it. Our goal here is simply to illustrate
the importance and inevitability of immune mediated dose-timing
effects so as to stimulate further empirical and theoretical work.
The structure of the paper is as follows: in the methods section
we describe the Cumulative Dose model and analyze its dynamics.
In the results section we use the Cumulative Dose model to fit
experimental data assuming a fixed temporal exposure window to
simulate the archetypical single dose experiment of dose-response
trials. Using the estimated model we show the effect of changing
the length of the temporal exposure window. Finally, the
conclusions and future research are presented in the discussion
section.
Methods
Cumulative Dose Model
The model is based on a stochastic population of individual
pathogens and immune effectors. Since the focus of our analysis is
how small populations of pathogens either die out or lead to
infection initiation, we cannot rely on the mean-field solution
provided by the deterministic framework [12–14].
The state of the system is defined by the pair (I, P) representing
the number of immune effectors and the number of pathogens, in
any single host, respectively. The system is defined by the following
set of state transitions:
I,P ðÞ DCCA
aIzPlI Iz1,P ðÞ ð 1Þ
I,P ðÞ DCCA
IcIzPIdI I{1,P ðÞ ð 2Þ
I,P ðÞ DCCA
aPzPhP I,Pz1 ðÞ ð 3Þ
I,P ðÞ DCCA
PIdP I,P{1 ðÞ ð 4Þ
The number of immune effectors I can increase at: 1) a rate aI,
which models the constant arrival of immune effectors regardless of
the current state of the immunological system; and 2) a rate PlI,
which models the recruitment of immune effectors in the presence
of pathogens. This term is intended to reflect cytokine induced
recruitment of remote immune effectors to a pathogen invasion site
and not acquired immunity. We assume that the relative endpoints
of infection takeoff or pathogen elimination are reached before an
acquired immune effect comes into play. Immune effectors decrease
either at a natural death rate cI, or at a mass-action deactivation
rate due to the encounter with pathogens PIdI.
The number of pathogens P can increase by reproduction at a
rate PhP or by arrival during the inoculation period at a rate aP.
Here hP represents the net reproduction rate that aggregates birth
and death rates. Pathogen numbers decrease due to interaction
with immune effectors as a mass-action deactivation process at the
rate PIdP.
Dynamics of the Cumulative Dose Model
The initial state of the system is set to I,P ðÞ t~0~
aI
cI
,0
  
.N o
chronic low-level exposures or remaining pathogens from prior
exposures are considered. The system starts from the clean state:
no pathogens and the stationary number of immune effectors in
the absence of pathogens. The inoculation process is characterized
by the dose of exposure De and the temporal exposure length Te;
i.e., the dose that is composed by De pathogens is inoculated into
the host during a period of Te time units. Therefore, the arrival of
external pathogens is modeled as the rate aP~
De
Te
during the
inoculation period. Once inoculation has finished the pathogen
arrival rate becomes zero. Thus, the rate aP depends on time and
is defined as
aP~
De
Te tƒTe
0 twTe
(
During tvTe, the pathogens, De arrive over a continuous time
in the presence of the immunological response to those pathogens.
Once the inoculation has finished, only the immunological
response remains. We set the unit of time to an hour. That keeps
us in the range where we think exposure fluctuations are making a
difference and out of the range where adaptive immune system
feedbacks come into play.
Due to stochastic effects and the fate of a relatively small
population of pathogens and immune effectors, the same
Author Summary
We model the relationship between the temporal patterns
of pathogen exposure and infection take off within people.
Since different routes of transmission (e.g., airborne versus
surface transfer routes) may result in different temporal
patterns of exposure, this model helps to better compare
the risks of transmission from one person to another
through these different routes. Previous models assumed
that the risk of infection is the same whether pathogens
are inoculated all at once or over one day. Our model, in
contrast, captures how one pathogen affects the potential
of immunity to keep concurrently or subsequently arriving
particles from initiating an infection. Since the pattern of
timing of airborne and surface spread pathogen arrivals
differ, our model shows that each airborne pathogen could
carry less risk than each surface transmitted pathogen.
Unfortunately, data to fully fit our model are not currently
available. Therefore new experiments will have to be
conducted where doses are given across different tempo-
ral windows.
Infectious Dose Timing Effects
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not necessarily have the same outcome. Each replication (i.e. run)
of the model corresponds to a dose trial on a new subject. All the
numerical results are the average of 10
4 runs of the Cumulative
Dose model implemented with the Gillespie algorithm [15] using
C. The criteria to stop the simulation is either extinction of
pathogens after the inoculation period (P~0, twTe) or pathogens
diverging to a very large number, Pwmax 204,5 |De
  
&I~0,
corresponding to no infection and infection respectively. The
probability of infection for a pair De, Te fg is the proportion of
simulations that diverge to a large number as opposed to
equilibrating to the state of no pathogens.
Figure 1 illustrates the stochastic process effects on pathogen
dynamics given a fixed time of exposure for different inoculation
doses. The main plot in this figure is the time course of the number
of pathogens for 100 independent dose trials given a dose of 60
pathogens administered over one unit of time. The number of
pathogens steadily grow during the inoculation period, from 0 to
1, since the rate of arrival of pathogens (aP~
De
Te
) is much faster
than immunological killing of pathogens. Once the entire dose has
been inoculated at time=1, the external arrival of pathogens stop
(aP~0) and the immunological response dominates the rest of the
dynamics. In this particular case, the population of pathogens
becomes extinct in 33 cases out of 100, thus, the probability of
infection given a dose of 60 pathogens over 1 unit of time is 0.67.
Analogously, for a dose of 25 the probability of infection is 0.02
and for a dose of 90 the probability of infection is 0.98 (insets of
Figure 1).
Temporal Exposure Length
Figure 1 illustrates how the Cumulative Dose model yields
higher probability of infection when the inoculated dose is
increased. The length of time over which the dose is administered,
Te, also plays a crucial role in the probability of infection. At one
extreme where all the pathogens were inoculated at once (Te?0),
the immune system has no time to react, and the initial state of the
system is I, P ðÞ ~
aI
cI
, De
  
. From this initial state, the immuno-
logical response dynamics determines the fate of the pathogens:
either extinction or unbounded growth of pathogens diverging
towards infinity.
For Tew0, however, the initial state after all pathogens have
been inoculated (t~~Te) is not the expected I, P ðÞ ~
aI
cI
, De
  
,
but rather a distribution of probabilities over the space of possible
Figure 1. Evolution of the number of pathogens over time for a characteristic parameter set hP, dP, aI, ªI, dI, lI fg fg ~
f0:15, 0:01, 0:4, 0:01, 0:005, 0:05 fg g. Each line represents an individual replicate with the same parameter set (100 in total). The fraction of replicates
in which the number of pathogens diverge towards infinity, as opposed to going extinct, is equivalent to the probability of infection (pinf) for the
dose De~60 (main graph, De~25 and De~90 for the insets a) and b) respectively). Temporal exposure length is fixed at Te=1 hour. Probability of
infection is 0.67, 0.02 and 0.98 for the main graph, the inset a), and the inset b) respectively.
doi:10.1371/journal.pcbi.1000399.g001
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system states at the point in Figure 1 where the exposure time has
just ended. It illustrates the effect of different temporal exposure
lengths, ranging from Te~0:1 (six minutes) to Te=50 hours.
Panel B shows this point of time for the settings in Figure 1. The
longer the exposure length, the larger will be the variance in the
distribution of probabilities. Furthermore, a longer exposure
length also affects the average state after inoculation. Both the
pathogen levels and the immune effector levels decrease from the
instantaneous inoculation values as the exposure window length
increases. But the balance between these increasingly favors the
immune effectors. Longer temporal exposure lengths dilute the
arrival rate of external pathogens, aP~
De
Te
. Consequently the
immunological response has more time to neutralize the existing
pathogens before the arrival of new pathogens. On the other hand,
as the temporal exposure lengths decrease, an increased number of
immune effectors are consumed in killing pathogens, leading to a
higher probability of unbounded growth of pathogens, and thus
infection.
For Te~0:1 and Te~1:0 the average state after inoculation is
very close to the ideal instantaneous inoculation, I, P ðÞ ~ 40, 60 ðÞ .
To better understand the dynamics once inoculation is over, we
included the numerically calculated separatrix as if the system
were deterministic (red-dashed line in Figure 2). Although this
separatrix is only truly valid for the analogous deterministic model,
it indicates the probable fate of different initial states. For the
deterministic system, the separatrix separates those states that go
to infection from those that do not (see subsection on Deterministic
Analysis). As temporal exposure length increases, the distribution
of probabilities gravitates towards the space of states that go to no-
infection (below the separatrix).
Deterministic Analysis
Further understanding of the stochastic dynamics of the
Cumulative Dose model can come from a deterministic descrip-
tion of the system that assumes a continuous large number of
immune effectors and pathogens. We focus our analysis on the
dynamics after the inoculation period, so aP is set to 0 and
removed from the equations. This analysis on the deterministic
version helps illustrate the interactions between pathogens and
immune effectors that result either in infection or extinction of
pathogens.
Figure 2. State probability distribution at the end of inoculation (t~Te) for a dose of De~60 and temporal exposure length of
Te~A) 0.1 h, B) 1.0 h, C) 10.0 h and D) 50.0 h. The distribution of probabilities if Te~0 would be I, P ðÞ ~ 40, 60 ðÞ given the parameters of the
system are hP, dP, aI, cI, dI, lI fg ~ 0:15, 0:01, 0:4, 0:01, 0:005, 0:05 fg . The dashed white line is the separatrix of the deterministic version of the
model (see subsection Deterministic Analysis); if the system were deterministic once inoculation has been completed, the states that fall below the
separatrix would end up in no infection, and the states above would end up in infection.
doi:10.1371/journal.pcbi.1000399.g002
Infectious Dose Timing Effects
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equation [16], which can be expanded in a deterministic
formulation known as macroscopic law. The deterministic version
of the cumulative dose model is as follows,
dI
dt
~aIzPlI{IcI{PIdI ð5Þ
dP
dt
~PhP{PIdP ð6Þ
where P and I are continuous variables of the population of
pathogens and immune effectors respectively. The fixed points of
the deterministic version of the cumulative dose model are
s ~
aI
cI
,0
  
where the pathogen has been eliminated and
immune effectors are in equilibrium and
r ~
hP
dP
,
hPcI{aIdP
lIdP{hPdP
  
where the forces of pathogen growth
are balanced by immune dynamics affecting pathogen death. Note
that in the stochastic analyses of this model as in Figure 1, this
point is never reached. Instead simulations are terminated when
growth takes off toward this point. A simple analysis of the stability
of the fixed points reveals the space of parameters in which the
solution is well-defined.
The point s  is the equilibrium of no infection—the equilibrium
of the system in the absence of pathogens. When the system
gravitates towards s  the immunological system prevents patho-
gens from growing, resulting in pathogen extinction and therefore
no infection.
To evaluate the stability of the fixed point, we formulate the
Jacobian matrix of the system of equations on s .
J~
{cI{PdI {IdIzlI
{PdP hP{IdP
  
ð7Þ
For a stable equilibrium, both Eigenvalues of the Jacobian
matrix need to be negative, or equivalently, the matrix must have
a negative trace and a positive determinant. For the trace of the
Jacobian to be negative the condition
hP
dP
v
aI
cI
zcI must be true.
Since the positive determinant condition,
hP
dP
v
aI
cI
, is more
restrictive it subsumes the condition for a negative trace.
The second fixed point r  is only well-defined when both I and
P are positive, since negative number of pathogens and immune
effectors are impossible. The number of pathogens is only positive
when sign hPcI{aIdP ðÞ ~sign lIdP{hPdI ðÞ . Given the condition
of a positive determinant,
hP
dP
v
aI
cI
, the sign can only be negative,
consequently
lI
dI
v
hP
dP
. Therefore, the system is well defined — i.e.
has a stable equilibrium at no infection and with both fixed points
in the positive quadrant — only when the following condition 8 is
met
li
di
v
hp
dp
v
ai
ci
ð8Þ
Once we determine the stability of s  we need to characterize
the second fixed point r . After some basic algebra, the
determinant of the Jacobian matrix for r  can be expressed as
follows: {
hPcI{aIdP
lIdP{hPdI
  
hPdI{dPlI ðÞ . Given condition 8, both
terms are positive, which makes the determinant negative. As a
result the Eigenvalues of the Jacobian are real with different signs.
Therefore, r  is a saddle point as shown in Figure 3.
The vector field in Figure 3 illustrates the dynamics of the
cumulative dose after the inoculation period. The probability of
being in a given state after inoculation is shown in Figure 2. If the
system were deterministic then we could anticipate the probability
of infection by summing the probability of those states below the
separatrix. This does not hold for the stochastic Cumulative Dose
model. Nonetheless, the deterministic vector field, shown in
Figure 3, serves as an approximate description of what happens in
the stochastic model.
For instance, let us take the probability distribution of states when
centered at I, P ðÞ ~ 40, 60 ðÞ , i.e., De~60 and Te~1. The typical
dynamic results in the decrease in number of pathogens and immune
effectors, gravitating towards the saddle point r , from which it will
bifurcate to the stable point of no-infection s ,o ra nu n b o u n d e d
growth of pathogens. In the case of De~60 and Te~50,m o s to ft h e
states are already very low in pathogens, and consequently the
number of immune effectors will eradicate the few pathogens still
existing and go to the stable equilibrium of no infection. However,
there is a non-zero probability, albeit small, of being in a state with a
large number of pathogens and a small number of immune effectors.
In this case, stochastic perturbations aside, the pathogens will keep
multiplying producing infection in the host.
Results
Analysis of Exposure Dose Risks
In this section, we fit empirical data on multiple pathogens for
the single event inoculation scenario. Next, we extend our analysis
to incorporate different temporal exposure windows and patterns
of inoculation.
Fitting experimental dose-response data. We selected
three different pathogen datasets: 1) poliovirus [17], 2)
Cryptosporidium parvum [18] and 3) rotavirus [19]. Analyses of
these three datasets are found elsewhere [20].
Several statistical models based on the empirical data have been
proposed to describe dose-response data. The most common
models are the Exponential model [1]:
Pinf~1{e{mr ð9Þ
where m is the inoculation dose and r is the per pathogen risk, and
the Beta-Poisson model [21]:
Pinf&1{ 1z
m
b
   {a
ð10Þ
where m is the inoculation dose and a and b are parameters of the
beta distribution that describes the host pathogen interaction.
Other models such as Log-Logistic and Weibull have been used,
but not as commonly.
For parameter estimation we used a classical genetic algorithm
[22]. The fitness function of the genetic algorithm was the mean
square error (MSE). We fixed the exposure time (Te) of our
inoculated dose (De) to 1.0 time units in order to emulate the
empirical dose-response experiments in which the dose is
inoculated in a single shot; i.e., a very short exposure. We present
the best fitting curves and discuss their limitations in the subsection
‘‘The Effect of Temporal Exposure Length’’. Then, given these
Infectious Dose Timing Effects
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temporal exposure windows on the final probability of
infection.
Poliovirus
The first empirical dataset to which we apply the Cumulative
Dose model is Poliovirus type 1 [17]. The cohort for this
experiment was 32 2-month-old infants. Inoculation was oral.
Figure 4 and Table 1 show the fit alongside a fit to the Exponential
model (EM) according to [18].
Cryptosporidium
The cohort for the Cryptosporidium parvum study [18] was 35
healthy subjects (12 men and 17 women, age range between 20
and 45 years). The strain was an isolate from a calf and the
inoculums were orally administered via capsules. Figure 5 and
Table 2 show the fit alongside a fit to the Exponential model (EM)
according to [20].
Rotavirus
Finally, we tested the Cumulative Dose model against a dataset
for Rotavirus [19].
The cohort for rotavirus was 62 adult males, 18 to 45 years old.
The inoculation was oral. Unlike the previous dose-response
empirical datasets, neither the Cumulative Dose model nor the
Exponential model produce a good fit. The Beta-Poisson model
(BP) was statistically a better fit than the Exponential model [20].
Both the Exponential and the Cumulative Dose model increase
too rapidly in relation to the probability of infection of 1; i.e. these
models cannot maintain a non-zero or non-one probability of
infection for a dose range of several orders of magnitude.
Conversely, the Beta-Poisson model does not suffer from this
limitation since its convergence to 1 is slower, providing a wider
range of variance (Figure 6 and Table 3).
A possible explanation of the poor fit of the Cumulative Dose
model is the high degree of acquired immunity to Rotavirus and
the changing serotype profile circulating within populations [23].
Unlike the polio virus study, the rotavirus cohort consisting of
adults (18–45 years old), is likely to have been exposed multiple
times to various rotavirus serotypes [24]. Such heterogeneity in
susceptibility flattens out dose response curves beyond what can be
captured by exponential dose response models or this Cumulative
Dose response model.
The Effect of Temporal Exposure Length
In the previous subsections we fixed temporal exposure length,
Te, to 1 hour, and assume that this is the time corresponding to
the single shot inoculation, analogous to existing experimental
dose-response trials. In this section, we present simulations for a
range of different temporal exposure lengths, illustrating how
longer times affect the dose response curve. The model is set to the
parameters that provided an optimal fit for a temporal exposure
length of Te~1:0.
Figure 7 shows the dose-response curves for Poliovirus type 1 for
different lengths of exposure for the estimated parameters used in
Figure 4 to fit the experimental data for the condition
Te=1.0: hP, dP, aI, cI, dI,lI fg ~ 1:0151,1:0431,16:8190,0:7831, f
1:7881, 1:4041g.Astheexposurelengthincreases,theprobabilityof
Figure 3. Vector field plot of the deterministic cumulative dose model for a characteristic parameter set hP, dP, aI, ªI, dI, lI fg fg ~
0:15, 0:01, 0:4, 0:01, 0:005, 0:05 fg fg . To avoid overlaps of the vectors they have been normalized. The solid red lines are the nullclines, the
intersections of the nullclines are the fixed points s  (stable pathogen elimination equilibrium) and r  (unstable saddle point equilibrium). The dash
black line is the separatrix that separates those configurations that will go to non-infection equilibrium, s , and those that will diverge in the number
of pathogens resulting on infection. The separatrix has been calculated numerically.
doi:10.1371/journal.pcbi.1000399.g003
Infectious Dose Timing Effects
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time is one hour, and this is the equivalent for a dose that is
administered in a single shot, the probability of infection generated
by the Cumulative Dose model for a dose of De of 90 pathogens
administered in one hour is 0.82. If the dose were administered not
in one hour, but uniformly over ten hours the probability of
infection would be 0.18. If the dose were administered over fifty
hours the probability of infection would be reduced to 0.0001. To
obtain the same probability of infection for a ten hours inoculation
period instead of one, we would require a dose of 139 pathogens
instead of 90.
Because data on the impact of temporal patterns of inoculation
are currently not available, a model with dose-time dependence
such as ours is not identifiable [25]; i.e., the model can be fit to
existing single dose empirical data with many different parameters
sets. For example, in Figure 8 we show model simulation results for
Cryptosporidium parvum for two different parameter sets. Both
parameters sets have a similar fit to the Cryptosporidium parvum
dataset when Te~1:0 (mean square error using S and R is
3.5610
23 and 9.7610
23 respectively). For values of Tew1,
however, the dose response relationships of the two parameter sets
diverge. Parameter set S is much less sensitive to exposure time
Figure 4. Dose-response curves based on the Exponential Model (EM) and the Cumulative Dose model (CD) compared to the
experimental dataset for Poliovirus type 1 (squares). The estimated parameters are ^ r r~9:0|10{3 for the Exponential model [3] and
hP, dP, aI, cI, dI, lI fg ~ 1:0151, 1:0431, 16:8190, 0:7831, 1:7881, 1:4041 fg for the Cumulative Dose model.
doi:10.1371/journal.pcbi.1000399.g004
Table 1. Probability of infection from experimental data for Polivirus type 1 (Pinf) compared to the probability of infection based
on the Exponential model (EM) and the Cumulative Dose model (CD).
Dose No. of subjects No. Infected Fraction Infected Pinf EM Pinf CD Pinf
7.0 1 0 0.0 0.0617 0.0
16.0 2 0 0.0 0.1355 0.0
27.0 2 0 0.0 0.2178 0.0062
42.0 1 0 0.0 0.3176 0.0831
50.0 6 3 0.50 0.3656 0.1840
55.0 3 1 0.333 0.3938 0.2582
65.0 6 0 0.0 0.4465 0.4523
80.0 1 1 1.0 0.5171 0.6992
90.0 4 3 0.75 0.5591 0.8189
160.0 3 3 1.0 0.7668 0.999
210.0 2 2 1.0 0.8521 1.0
280.0 1 1 1.0 0.9218 1.0
The estimated parameters are ^ r r~9:0|10{3 for the Exponential model [3] and hP, dP, aI, cI, dI, lI fg ~ 1:0151, 1:0431, 16:8190, 0:7831, 1:7881, 1:4041 fg for the
Cumulative Dose model.
doi:10.1371/journal.pcbi.1000399.t001
Infectious Dose Timing Effects
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proliferate faster, are being eliminated by each immune effector
more quickly, are recruiting fewer immune effectors, and are
eliminating immune effectors at a slower rate. On the other hand,
using parameter set R, the natural rate of turnover of immune
effectors is more rapid. We cannot argue at this point which is the
most plausible configuration since identifiability cannot be
resolved without data from dosing trials for different exposure
lengths.
The Effect of Dosing Patterns over the Exposure Window
In this section we relax the assumption that pathogens are
inoculated at a fixed rate. We allow variation both in dose
magnitude and length of exposure time, in order to capture a more
realistic exposure scenario.
The temporal pattern of inoculation of pathogens within a host
depends both on the behavior of the host and the contamination of
the environment the host interacts with. For instance, a susceptible
host in a venue contaminated with influenza will be exposed to
pathogens from air and fomites. However, the temporal patterns of
exposure for these two modes of transmission are different. The host
is likely to receive a small dose with every breath when breathing
contaminated air. In fomite mediated transmission, however, the
touching of a mucous membrane with contaminated fingers, for
example, is likely to transmit a larger but less frequent dose.
To illustrate this effect we devised an experiment where both
the total inoculated dose De and the exposure time length Te are
fixed. The only parameter that varies is the number of inoculation
events, Fi, which ranges from 1 to the total dose De. Consequently,
once the number of inoculations events is determined, the dose
Figure 5. Dose-response curves based on the Exponential Model (EM) and the Cumulative Dose model (CD) compared to the
experimental dataset for Cryptosporidium parvum (squares). The estimated parameters are ^ r r~4:005|10{3 for the Exponential model [30]
and hP, dP, aI, cI, dI, lI fg ~ 2:1721, 1:7971, 2:8020, 0:9570, 2:2681, 2:7131 fg for the Cumulative Dose model.
doi:10.1371/journal.pcbi.1000399.g005
Table 2. Probability of infection from experimental data for Cryptosporidium parvum (Pinf) compared to the probability of
infection predicted by the Exponential model (EM) and the Cumulative Dose (CD) model.
Dose No. of subjects No. Infected Fraction Infected Pinf EM Pinf CD Pinf
34 5 1 0.2 0.1273 0.0848
108 8 3 0.375 0.3511 0.3173
313 3 2 0.6667 0.7145 0.7421
504 6 5 0.8333 0.8671 0.9065
1129 2 2 1.0 0.9891 0.9972
11460 3 3 1.0 1.0 1.0
113900 1 1 1.0 1.0 1.0
1139000 1 1 1.0 1.0 1.0
The estimated parameters are ^ r r~4:005|10{3 for the Exponential model [30] and hP, dP, aI, cI, dI, lI fg ~ 2:1721, 1:7971, 2:8020, 0:9570, 2:2681, 2:7131 fg for the
Cumulative Dose model.
doi:10.1371/journal.pcbi.1000399.t002
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De
Fi and the rate at which inoculation
occur is
Fi
Te.
Figure 9 shows the results of this experiment where the same
parameter sets are used as in Figure 8. The pathogen is
Cryptosporidium parvum, and the same two different parameters sets,
S and R, are used to inform the cumulative dose model. The total
dose inoculated is set to De~300 and the temporal exposure
length is set to Te=120.0 hours.
For both parameter sets S and R we observe the same behavior:
infectivity decreases as the frequency or number of inoculations
events increases. The temporal pattern more likely to be associated
with fomite transmission (low frequency and high dose, Figure 9.B)
is more likely to produce infection than the patterns associated
with airborne transmission (high-frequency and low dose,
Figure 9.C) .
For parameter set R, the probability of infection if the dose is
inoculated with a single exposure (Figure 9.A) is 0.752. The same
dose inoculated over 4 events, where each event is one fourth of
the total dose (Figure 9.B), reduces the probability of infection to
0.443. In addition, if the dose is inoculated over 50 events
(Figure 9.C) the probability decreases to 0.111. For parameter set
S, the reduction of the infection probability is less pronounced:
0.740, 0.676 and 0.601 for 1, 4 and 50 inoculation events
respectively.
Figure 6. Dose-response curves based on the Exponential Model (EM), the Beta-Poisson model (BP) and the Cumulative Dose
model (CD) compared to the experimental dataset for Rotavirus (squares). The estimated parameters are^ r r~1:0|10{1 for the Exponential
model, ^ a a, ^ b b
no
~ 0:253, 0:422 fg for the Beta-Poisson model [31] and hP, dP, aI, cI, dI, lI fg ~ 7:499, 2:811, 11:621, 3:490, 2:823, 7:512 fg for the
Cumulative Dose model.
doi:10.1371/journal.pcbi.1000399.g006
Table 3. Probability of infection from experimental data for Rotavirus (Pinf) compared to the the Exponential, Beta-Poisson and
Cumulative Dose models.
Dose No. of subjects No. Infected Fraction Infected Pinf EM Pinf BP Pinf CD Pinf
9610
23 5 0 0.0 0.0009 0.0053 ,0.001 (*)
9610
22 7 0 0.0 0.009 0.0477 0.0053
9610
21 7 1 0.1428 0.0861 0.2509 0.0740
9 11 8 0.7273 0.5934 0.5442 0.6175
9610
1 7 6 0.8571 0.9999 0.7428 0.9999
9610
2 8 7 0.875 1.0 0.8562 1.0
9610
3 7 5 0.7143 1.0 0.9197 1.0
9610
4 3 3 1.0 1.0 0.9551 1.0
The estimated parameters are ^ r r~1:0|10{1 for the Exponential model, ^ a a, ^ b b
no
~ 0:253, 0:422 fg for the Beta-Poisson model [31] and
hP, dP, aI, cI, dI, lI fg ~ 7:499, 2:811, 11:621, 3:490, 2:823, 7:512 fg for the Cumulative Dose model. (*) The dose in the original trial was administered in concentrations,
to work with discrete pathogens as required by the Cumulative Dose model, we assumed that the concentration of 9610
22 is equivalent to 9 pathogens. As a
consequence the concentration of 9610
23 could not be tested since it is a fraction of a pathogen. The probability of infection for a single pathogen is 10
23. This
assumption is only required by the Cumulative Dose model.
doi:10.1371/journal.pcbi.1000399.t003
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lengths decrease infectivity due to the action of the immune
system. In this section, we show that not only the duration of the
exposure matters, but also the way in which pathogens arrive
within that interval can decrease infectivity. These results suggest
that risk assessments based on current dose-response data might be
over-estimating risk of infection. An important corollary is that risk
of infection for a given exposure dose may depend on the route of
transmission based on their differences in the pattern of exposure.
Discussion
We examined a dynamic mechanistic model where immune
system effects generated dose response dependence on the timing
of doses. The specific aspects of our model that generate these
dose-timing effects are: 1) decreases in available immune effectors
because they are being eliminated as they kill pathogens; and 2)
increases in available immune effectors due to both pathogen
dependent and independent recruitment. An additional mecha-
nism resulting in decreases in available immune effectors that is
not included in our model could be the time of immune effector
engagement with pathogens in the killing process. The dose-timing
effects we illustrate would be absent in a model where some
effector like a T-cell instantaneously kills pathogens or pathogen
generating cells, where no killing capacity is lost with each kill, and
where effector dynamics are not otherwise altered by encounters
with pathogens. Any such model, however, is highly unrealistic,
and therefore we conclude that the dose-timing effects presented in
our model could be important and warrant further study.
Dose-timing effects have implications for microbial risk
assessment, for infection transmission system modeling, and for
the evolution of emerging pathogens. Considering a microbial risk
assessment example, the implications of our findings suggest that
exposure routes with different dose-timing dynamics could have
different risks and therefore result in different clean up protocols
for contamination events such as a norovirus outbreak or a
Katrina-like disaster. Dose timing could, therefore, affect decisions
on which venues to close or what the total dose that workers would
be permitted to accrue during a cleanup operation.
Considering modeling infection transmission, the standard
approach is to define a contact and a transmission probability
per contact while the physical route of transmission is ignored.
Modeling the physical route of transmission is important when it is
Figure 7. Predicted effects of varying exposure times (Te) when inoculated with Poliovirus type 1. Parameters are defined as stated in
Figure 4.
doi:10.1371/journal.pcbi.1000399.g007
Figure 8. Predicted effects of varying exposure times (Te) when
inoculated with Cryptosporidium parvum. The top graph comes
from simulations using the parameter set defined in Figure 5. The
bottom graph comes simulations using the parameter set
R~ hp,dp,ai,ci,di,li
  
~ 4:4901,2:2761,7:4790, 1:2570,0:4241,0:7871 fg .
doi:10.1371/journal.pcbi.1000399.g008
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particular public venues and when specifying which control
actions in these venues will reduce transmission. When different
routes have different temporal exposure patterns, we demonstrate
here that there is considerable potential for immune system effects
to alter the ratio by which airborne transmitted and hand-fomite
transmitted pathogens generate new infections. If we had data on
infection risks under different dose-timing patterns, we could say
more precisely how much difference in risk there might be from an
airborne and a hand-fomite mediated pathogen. Unfortunately
such data is lacking.
The evolution of emerging infection implications derive from
the route of transmission effects just discussed. When pathogens
first jump species, they are likely to encounter strong innate
immune responses to which they must evolve some escape
strategy. That means very high transmission doses will be required
to sustain transmission and that low dose exposure over longer
times such as occurs with airborne transmission will be the most
unlikely to be effective in transmitting infection. But, as escape
from innate immune responses evolves, the balance could begin to
favor airborne transmission which might be more effective in
disseminating infection.
We do not have enough dose timing data for any infection to
evaluate either the microbial risk assessment implications, the
infection transmission system implications, or the emerging
infection evolution implications. Any data providing indications
of the magnitude of dose-timing effects generated by any type of
immunity to any agent would provide an important first step that
would at least indicate what range of effects might be expected.
Animal studies could compare the risks associated with a single
instantaneously delivered dose with the same dose magnitude
delivered over extended periods of time. Measurements of specific
immune effector dynamics, such as interferon gamma [26] would
improve our mechanistic understanding of a cumulative dose
effect and indicate how to refine our models for different animal/
pathogen systems.
The issue of dose-response trial design is crucial for advancing
both quantitative microbial risk assessment and analysis of
population infection transmission systems. Due to the absence of
a prior theoretical framework, there has been no motivation to
conduct dosing trials that take multiple doses and multiple dosing
times into account. Now that the potential effects of dose timing
have been demonstrated and the practical significance of such
measurements for microbial risk assessment and transmission
system analyses is more evident, we hope to see such experiments.
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Figure 9. Predicted effects of different temporal patterns of exposure when inoculated with Cryptosporidium parvum. The main
figure displays the probability of infection as function of the number of inoculation events. The line with circular markers comes from simulation
results using the parameter set defined in Figure 5, and the line with square markers comes from simulation results using the parameter set
R~ hP, dP, aI, cI, dI, lI fg ~ 4:4901, 2:2761, 7:490, 1:2570, 0:4241, 0:7871 fg The insets below demonstrate three temporal patterns for three
different patterns of inoculation events: A=1, B=4 and C=50 events respectively. The solid line represents one instance of the 5000 replicas used in
the experiment. The dashed line represents the average of dose inoculated over time.
doi:10.1371/journal.pcbi.1000399.g009
Infectious Dose Timing Effects
PLoS Computational Biology | www.ploscompbiol.org 11 June 2009 | Volume 5 | Issue 6 | e1000399References
1. Haas CN, Rose JB, Gerba CP (1999) Quantitative Microbial Risk Assessment.
New York: John Wiley & Sons, Inc., ISBN: 0-471-18397-0.
2. Noakes CJ, Beggs CB, Sleigh PA, Kerr KG (2006) Modelling the transmission of
airborne infection in enclosed spaces. Epidemiology and Infection 134(5):
1082–91.
3. Eisenberg JNS, Lei X, Hubbard AH, Brookhart MA, Colford Jr JM (2005) The
role of disease transmission and conferred immunity in outbreaks: Analysis of the
1993 Cryptosporidium outbreak in Milwaukee. American Journal of Epidemi-
ology. pp 62–72.
4. Atkinson MP, Wein LM (2008) Quantifying the routes of transmission for
pandemic influenza. Bull Math Biol 70: 820–867.
5. Ellenberger D, et al. (2006) HIV-1 DNA/MVA vaccination reduces the per
exposure probability of infection during repeated mucosal SHIV challenges.
Virology 352: 216–225.
6. Garcia-Lerma JG, et al. (2008) Prevention of rectal SHIV transmission in
macaques by daily or intermittent prophylaxis with emtricitabine and tenofovir.
PLoS Med 5: e28. doi:10.1371/journal.pmed.0050028.
7. Tuckwell HC, Shipman PD, Perelson AS (2008) The probability of HIV
infection in a new host and its reduction with microbicides. Math Biosci 214:
81–86.
8. Van Rompay KK, Kearney BP, Sexton JJ, Colon R, Lawson JR, Blackwood EJ,
Lee WA, Bischofberger N, Marthas ML (2006) Evaluation of oral tenofovir
disoproxil fumarate and topical tenofovir GS-7340 to protect infant macaques
against repeated oral challenges with virulent simian immunodeficiency virus.
J Acquir Immune Defic Syndr 43: 6–14.
9. Van Rompay KK, et al. (2005) Attenuated poxvirus-based simian immunode-
ficiency virus (SIV) vaccines given in infancy partially protect infant and juvenile
macaques against repeated oral challenge with virulent SIV. J Acquir Immune
Defic Syndr 38: 124–134.
10. Wilson NA, et al. (2006) Vaccine-induced cellular immune responses reduce
plasma viral concentrations after repeated low-dose challenge with pathogenic
simian immunodeficiency virus SIVmac239. J Virol 80: 5875–5885.
11. Brachman PS, Kaufman AF, Dalldorf FG (1966) Industrial inhalation Anthrax.
Bacteriol Rev 30: 646–659.
12. Rand DA, Wilson HB (1991) Chaotic stochasticity: a ubiquitous source of
unpredictability in epidemics. Proc Royal Society B 246: 179–184.
13. McKane AJ, Newman TJ (2005) Predator-prey cycles from resonant
amplification of demographic stochasticity. Physical Review Letters 94: 218.
14. Alonso D, McKane AJ, Pascual M (2006) Stochastic amplification in epidemics.
J R Soc Interface; 10.1098/rsif.2006.0192.
15. Gillespie DT (1976) A general method for numerically simulating the stochastic
time evolution of coupled chemical reactions. Journal of Computational Physics
22: 403–434.
16. van Kampen NG (1992) Stochastic processes in physics and chemistry.
Amsterdam: Elsevier.
17. Minor TE, Allen CI, Tsiatis AA, Nelson DB, d’Alesio DJ (1981) Human
infective dose determinations for oral poliovirus type 1 vaccine in infants. Journal
of Clinical Microbiology 13(2): 388–389.
18. DuPont HL, Chappell CL, Sterling CR, Okhuysen PC, Rose JB, Jakubowski W
(1995) The infectivity of Cryptosporidium parvum in healthy workers. The New
England Journal of Medicine 332(13): 855–859.
19. Ward RL, Bernstein DI, Young EC, Sherwood JR, Knowlton DR, Schiff GM
(1986) Human Rotavirus studies in volunteers: determination of infectious dose
and serological response to infection. Journal of Infectious Diseases 154(5):
871–880.
20. Teunis PFM, van der Heijden OG, van der Giessen JWB, Havelaar AH (1996)
The dose-response relation in human volunteers for gastro-intestinal pathogens.
Rijksinstituut voor Volksgezondheid en Milieu Bilthoven 284550002.
21. Haas CN (1983) Estimation of risk due to low doses of microorganisms: a
comparison of alternative methodologies. American Journal of Epidemiology
118(4): 1097–1100.
22. Holland JH (1975) Adaptation in Natural and Artificial Systems. Ann Arbor:
University of Michigan Press.
23. Koopman JS, Monto AS (1989) The Tecumseh Study XV: Rotavirus infection
and pathogenicity. American Journal of Epidemiology 130(4): 750–759.
24. Koopman JS, Monto AS, Longini IM (1989) The Tecumseh Study XVI: Family
and community sources of rotavirus infection. Am J Epidemiol 130(4): 760–768.
25. Armitage P, Spicer CC (1956) The detection of variation in host susceptibility in
dilution counting experiments. Journal of Hygiene 54: 401–414.
26. Howat TJ, Barreca C, O’Hare P, Gog JR, Grenfell TB (2006) Modelling
dynamics of the type I interferon response to in vitro viral infection. J R Soc
Interface 3: 699–709.
Infectious Dose Timing Effects
PLoS Computational Biology | www.ploscompbiol.org 12 June 2009 | Volume 5 | Issue 6 | e1000399